XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 20,561,116 $ 32,007,792
Accounts receivable – trade, net 3,622,209 2,727,052
Other receivables (including $158,384 due from related parties – March 31, 2022 and $158,384 – December 31, 2021, refer to Note 19) 1,979,885 2,021,813
Inventories, net 9,405,920 9,659,536
Prepaid expenses 10,272,310 9,728,782
Total current assets 45,841,440 56,144,975
Property, plant, and equipment, net 8,480,180 6,841,026
Goodwill and other intangible assets, net 19,016,683 16,902,513
Operating lease right of use assets, net 1,051,139 993,384
Other assets 4,636,576 2,107,299
Total assets 79,026,018 82,989,197
Current liabilities:    
Accounts payable 7,726,667 4,569,106
Accrued expenses 1,061,821 1,175,998
Current portion of operating lease obligations 402,313 373,371
Contract liabilities – current portion 1,788,721 1,665,519
Debt obligations – current portion 662,717 389,934
Warrant derivative liabilities 14,698,761 14,846,932
Income taxes payable 16,827 1,827
Total current liabilities 26,357,827 23,022,687
Long-term liabilities:    
Debt obligations – long term 1,249,347 727,278
Operating lease obligation – long term 717,021 688,207
Contract liabilities – long term 3,221,537 2,687,786
Total liabilities 31,545,732 27,125,958
Commitments and contingencies
Stockholders’ Equity:    
Common stock, $0.001 par value per share; 100,000,000 shares authorized; shares issued: 49,728,357 shares issued – March 31, 2022 and 50,904,391 shares issued – December 31, 2021 49,728 50,904
Additional paid in capital 124,820,428 124,426,379
Noncontrolling interest in consolidated subsidiary (57,333) 56,453
Accumulated deficit (77,332,537) (68,670,497)
Total stockholders’ equity 47,480,286 55,863,239
Total liabilities and stockholders’ equity $ 79,026,018 $ 82,989,197